Justification treatment cost

Slides:

Advertisements

Similar presentations

Phase O Trials: Ethical Considerations Holly Taylor, PhD, MPH Department of Health Policy and Management Bloomberg School of Public Health Berman Institute.

Advertisements

Consideration for a Donation Economic Aspects Dr. Samuel Jellinek LL.D Faculty of Law The Hebrew University of Jerusalem Presented at Maastricht Medicine.

COCOM Kwaliteit van leven in maat en getal Jan van Busschbach.

Justice and Economic Evaluation Prof. Dr. Jan Busschbach

1 The Future of Quality of Life Assessment in Cost-Effectiveness Research Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.

1 Does it make a difference for the patient? Survival & Quality of life  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and.

1 A Health Economic View on Borderline Personality Disorder Prof. dr. Jan Busschbach Viersprong Institute for studies on Personality Disorders Medical.

(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy.

(Cost-)Effectiveness of Psychotherapy for Personality Disorders Prof. dr. Jan van Busschbach Department of Medical Psychology & Psychotherapy Erasmus MC.

1 Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren

QALYs and Ethics Prof. dr. Jan van Busschbach 11.

1 Dyslexia and Cost Effectiveness Prof. dr. Jan van Busschbach De Viersprong Erasmus MC.

1 GUIDELINES as a way of harmonisation in Europe: Pro’s and Con’s Prof. Dr. Jan. A. Swinkels Psychiatrist Professor in clinical guideline development in.

1 Cost-effectiveness in Personality Disorder Dr. J.J.V. Busschbach Psychotherapeutic centre ‘De Viersprong’ –PO Box AA Halsteren

BREAST HEALTH GLOBAL INITIATIVE(BHGI) SUPPORTIVE CARE GUIDELINES& THEIR ROLE IN ADVOCACY : The Uganda Experience Gertrude Nakigudde Patient Advocate Uganda.

Coronel Institute AmCOGG Review A tool for distinguishing gender research from gender difference research- examples from work-related health Author: A.

BACKGROUND Cost-effectiveness of Psychotherapy for Cluster C Personality Disorders and the Value of Information and Implementation Djøra I. Soeteman 1,2,

1 Reconciliation of Economic Arguments and Clinical Practice Monday November 4, 2002 ISPOR, Rotterdam Jan Busschbach PhD, –Department of Medical Psychology.

Quality indicators and their role in contractual relations between health care providers and health insurance companies Janka Jančovičová Health Care Surveillance.

BEAT-IT: A randomised controlled trial comparing a behavioural activation treatment for depression in adults with learning disabilities with an attention.

Mindfulness A brief introduction. Definition Simply- awareness- being in the present moment. “ Awareness of the present experience with acceptance” (Germer.

1 QALY, Burden of Disease and Budget Impact  Jan J.V. Busschbach, Ph.D.  Erasmus MC, Rotterdam, The Netherlands  

1 Monitoring Quality of Life in the Clinic Prof. dr. Jan van Busschbach Medical Psychology and Psychotherapy Erasmus MC.

Cost-effectiveness of psychotherapy for personality disorders Djøra Soeteman Viersprong Institute for Studies on Personality Disorders Erasmus Medical.

Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD)

1 Cost effectiveness as argument for reimbursement in prevention Jan J. v. Busschbach, Ph.D. Erasmus MC –Institute for Medical Psychology and Psychotherapy.

Mental Health Services, University of Copenhagen 1.

Economic evaluation of psychotherapy for personality disorders: burden of disease and cost-effectiveness Djøra Soeteman Viersprong Institute for Studies.

1 The Economic Burden of Personality Disorders  Djøra Soeteman, Jan J.V. Busschbach, Leona Hakkaart-van Roijen, Roel Verheul  Viersprong Institute for.

Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy Viersprong.

11 Cost Effectiveness in Preventing Crime  Jan van Busschbach, Djøra Soeteman  Viersprong Institute for studies on Personality Disorders VISPD  Erasmus.

Treatment selection in patients with personality disorders: The role of patient characteristics Helene Andrea Janine van Manen, Anna Bartak, Jan van Busschbach,

1 The Cost Effectiveness of Treatment of Personality Disorder  Dr. Jan J.V. Busschbach  PTC De Viersprong, Erasmus MC, Rotterdam, 

Cost-Effectiveness of Psychotherapy for Personality Disorders Soeteman, Busschbach, Verheul.

Cost-effectiveness in the quest to convince the outside world Dr. Jan Busschbach De Viersprong Erasmus MC

1 Cost Effectiveness  Jan J.V. Busschbach, Ph.D.  Viersprong Institute for studies on Personality Disorders VISPD  Erasmus.

1 Interactive Introduction Cost Effectiveness and Psychotherapy Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren

1 The Economics of Health Care and New Technologies Friday October 18, 2002 Between Technology and Humanity, Brussels Jan Busschbach PhD, –Department of.

“Introduction to Patient Preference Methods used for QALYs” Presented by: Jan Busschbach, PhD, Chair Section Medical Psychology and Psychotherapy, Department.

Workshop 18 th May 2010, Brussels Applying the Value+ model on patient involvement in HTA processes.

(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy.

Department of Health Service Research Head: Prof. Dr. Ansgar Gerhardus Interactive session: Presentation of the INTEGRATE-HTA Model and short discussion.

1 Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.

Fall 2011 Philosophy 2440 Prof. Robert N. Johnson Monday, March 14, 2016 MEDICAL ETHICS.

Dr Gen Wong Associate Clinical Director NHS Salford.

1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.

The burden of disease in patients with personality disorder indicated for psychotherapy: Arguments for necessity of care Djøra Soeteman, MSc

Health Economics & Policy 2 nd Edition James W. Henderson Chapter 9 Sociocultural Considerations Copyright 2002, South-Western, a division of Thomson Learning,

Lorenzo Refolo & M-D Kerns

The introduction of a routine offer of relapse prevention pharmacotherapy following successful alcohol withdrawal: A quality improvement project in a 20.

Interventions and their benefits Prof. Dr. Pim Cuijpers

Presentations to an Irish Eating Disorder Service – who are they

“New Technologies in Clinical Proteomics”

The Patient Journey to Remission in MDD: A Collaborative Approach

وزارت بهداشت درمان و آموزش پزشکی معاونت درمان

The Parkinson's Disease Psychosis Journal Club

A Patient has the Right to…..

Managing Depression is a Team Effort:

NRSG 790: Methods for Research and Evidence Based Practice

Insights Into the Spectrum of Tardive Dyskinesia

Treatment-Resistant Schizophrenia

How to apply successfully to the NIHR HTA Board?

Communicating With Your Patients About Major Depressive Disorder

Drafting Group: Final Meeting Drafting Group: 1st Meeting

Patient Engagement in Care Management for Chronic Condition, by Medical Home Percent reporting positive patient engagement in managing chronic condition*

Community Pharmacists Monitoring of Pulmonary Tuberculosis Outpatients (Preliminary Study)

Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.

The Real Burden of Rosacea

Attempted back-calibration by applying the MDRD to the laboratory-reported creatinine values. Recalibration reduces (green) the apparent step discontinuity.

Multimodal Approaches to Cracking the Code in Low Back Pain

Presentation transcript:

Justification treatment cost Prof. dr. Jan van Busschbach Medical Psychology and Psychotherapy Viersprong Institute for studies on Personality Disorders Erasmus MC

Justification treatment costs Effectiveness Savings elsewhere Certainty Dependency of others High burden Clear relation to health Low prevalence Cost effectiveness HTA Ethical considerations

Justification treatment costs Effectiveness Savings elsewhere Certainty Dependency of others High burden Clear relation to health Low prevalence ? Cost effectiveness ? ? HTA ? Ethical considerations ?

Justification treatment costs Effectiveness Savings elsewhere Certainty Dependency of others High burden Clear relation to health Low prevalence ? ? ? ? ? ? TOPGGZ 3rd ≠ 2nd ? ? Burden TOPGGZ 3rd > 2nd ? ? # patients TOPGGZ 3rd > 2nd Phase 1: Differentiation between 2nd and 3rd line care

Justification treatment costs Effectiveness Savings elsewhere Certainty Dependency of others High burden Clear relation to health Low prevalence ? ? Evidence of substitution ? ? Cost effectives models ? ? ? Phase 2: Cost Effectiveness

Earlier attempts 2008 Feb;69(2):259-65

Earlier attempts Nr. 04 - 25 januari 2008

Earlier attempts 2008 Jun;22(3):259-68

Earlier attempts 2011 Jan;72(1):51-9

Conclusion Not only cost effectiveness is important Burden is also important Both in terms of economic and quality of life Burden main target phase 1 Cost effectiveness phase 2